Myomo (MYO) Notes Payables (2016 - 2025)

Myomo (MYO) posted Notes Payables of $999418.0 for Q4 2025, up 1180.57% on a QoQ basis from $78045.0 in Q3 2020.

Myomo (MYO) Notes Payables (2016 - 2025) Analysis & Trends

Myomo's Notes Payables history runs 6 years deep, the most recent figure standing at $999418.0 for Q4 2025.

  • Quarterly Notes Payables changed N/A year-over-year to $999418.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $999418.0 (changed N/A YoY) and the FY2025 annual result came in at $999418.0, changed N/A from the prior year.
  • Notes Payables was $999418.0 for Q4 2025 at Myomo, up from $78045.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $999418.0 in Q4 2025 and bottomed at $999418.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.74 Bn 176.45 Bn 6.27 Bn
2 Stryker 128.89 Bn 126.01 Bn 3.81 Bn
3 Medtronic 108.48 Bn 99.26 Bn 6.41 Bn
4 Boston Scientific 68.51 Bn 67.05 Bn 3.61 Bn
5 Edwards Lifesciences 48.32 Bn 44.65 Bn 1.29 Bn
6 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn
7 GE HealthCare Technologies 28.23 Bn 25.95 Bn 1.98 Bn
8 Smith & Nephew 26.90 Bn 26.32 Bn -
9 Koninklijke Philips 24.47 Bn 21.35 Bn 2.07 Bn
10 Myomo 43.01 Mn 24.04 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 999,418.00
Sep 30, 2020 78,045.00
Jun 30, 2020 996,841.00
Mar 31, 2020 40,605.00
Dec 31, 2019 378,239.00
Sep 30, 2019 43,942.00
Jun 30, 2019 58,477.00
Mar 31, 2019 157,927.00
Dec 31, 2018 3,661.00
Sep 30, 2018 8,652.00
Jun 30, 2018 21,962.00
Mar 31, 2018 24,623.00
Dec 31, 2017 39,930.00
Sep 30, 2017 92,359.00
Dec 31, 2016 876,458.00